Assessing miRNA expression levels in tissue samples from CRC patients, Milanesi et al. found that miR-149-5p and seven other miRNAs were specifically down-regulated in CRC tissue samples with KRAS mutations. Here, KRAS is linked to colorectal carcinoma.